Atlas Trials

Nocturnal TLA for Severe Allergic Asthma After Withdrawal of Omalizumab Therapy

Clinical trial NCT03480815 · COMPLETED

Trial details

NCT number
NCT03480815
Sponsor
Chang Gung Memorial Hospital
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Severe Allergic Asthma
Start date
2017-01-20
Primary completion
2019-12-31
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.